Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Rheumatology
•
Infection-related arthritis
•
General Rheumatology
•
Infectious Disease
How do you approach evaluation for indolent infection in patients with chronic erosive arthropathy?
Related Questions
How often do you see bony erosions in patients with Lyme arthritis?
How do you integrate next-generation sequencing with traditional culture methods to improve the identification of fungal pathogens, especially in cases where routine cultures are negative when evaluating suspected prosthetic joint infections?
How would you treat an asymptomatic patient with a positive Blastomyces antibody, evidence of prior granulomatous lung disease on imaging, and who may require immunosuppression in the future?
In light of recent measles outbreaks, have you adjusted your vaccination counseling or preventive strategies for adult immunocompromised patients?
What specific criteria or patient conditions would make you hesitant to use fluoroquinolones early in the treatment course for managing MSSA joint infections with oral antibiotics?
Is there a risk of hepatitis C activation with rituximab in a patient who has a history of HCV treated with antivirals and who is in sustained viral response?
Do you routinely consider FDG PET/CT imaging for workup of fever of unknown origin?
Do you find HZV titers useful in diagnosing shingles sine herpete?
Is there a role for nitazoxanide for treatment of norovirus gastroenteritis in immunocompromised patients?
Should patients starting cyclophosphamide be screened routinely for latent tuberculosis (TB)?
